PHGUF - Pharming Group N.V.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0000 (0.00%)
At close: 2:59PM EST
Stock chart is not supported by your current browser
Previous Close1.5700
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.5700 - 1.5700
52 Week Range0.7850 - 1.8190
Avg. Volume5,180
Market Cap957.645M
Beta (5Y Monthly)1.40
PE Ratio (TTM)N/A
EPS (TTM)-0.0600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.67
  • PR Newswire

    Pharming Announces the Launch of an Offering of Approximately €125 Million Senior Unsecured Convertible Bonds due 2025

    Pharming Group N.V. ("Pharming" or the "Company") (Euronext Amsterdam: PHARM) announces today the launch of an offering (the "Offering") of approximately €125 million of senior unsecured convertible bonds due 2025 (the "Bonds"). The net proceeds of the issue of the Bonds will be used to redeem the approximately US$ 56 million loan with Orbimed Advisors in full, thereby reducing the Company's financing costs and extending its debt maturity through the period to approval of most of the Company's existing pipeline. The balance of the net proceeds will be used to support capital expenditure in relation to the expansion of the commercialisation and manufacturing infrastructure of the Company, and serve as funding for the launch of Pharming's recently acquired Leniolisib product and for additional acquisitions/inlicensing opportunities.

  • Is Pharming Group (AMS:PHARM) A Risky Investment?
    Simply Wall St.

    Is Pharming Group (AMS:PHARM) A Risky Investment?

    The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

  • Can Pharming Group N.V. (AMS:PHARM) Maintain Its Strong Returns?
    Simply Wall St.

    Can Pharming Group N.V. (AMS:PHARM) Maintain Its Strong Returns?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • Is Pharming Group N.V. (AMS:PHARM) A Volatile Stock?
    Simply Wall St.

    Is Pharming Group N.V. (AMS:PHARM) A Volatile Stock?

    If you own shares in Pharming Group N.V. (AMS:PHARM) then it's worth thinking about how it contributes to the...

  • PR Newswire

    Pharming Group Reports Strong Financial Results for the First Half of 2019

    LEIDEN, Netherlands, July 26, 2019 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) presents its (unaudited) interim financial report for the first half year ended 30 June 2019. The Company will hold a conference call at 13:00 CET / 07:00 EST today: dial-in details can be found on pages 4 and 5.